
BioNTech
Europe, Rheinland-Pfalz, Germany, Mainz
Description
BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.
Investor Profile
BioNTech has backed more than 6 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Post Ipo Equity, Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom, Germany, Poland.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series Unknown (33%)
- Post Ipo Equity (33%)
- Series B (17%)
- Pre Seed (17%)
Country Focus
- United Kingdom (50%)
- Germany (33%)
- Poland (17%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical
- Alternative Protein
- Food And Beverage
- Organic Food
- Sustainability
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does BioNTech frequently co-invest with?
Which angels does BioNTech often collaborate with?
What are some of recent deals done by BioNTech?
Find More Investors Like BioNTech
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










